MARCKS protein mediates hydrogen peroxide regulation of endothelial permeability
Impairment of endothelial barrier function is implicated in many vascular and inflammatory disorders. One prevalent mechanism of endothelial dysfunction is an increase in reactive oxygen species under oxidative stress. Previous reports have demonstrated that hydrogen peroxide (H ₂O ₂), a highly stab...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 109; no. 37; pp. 14864 - 14869 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
11.09.2012
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Impairment of endothelial barrier function is implicated in many vascular and inflammatory disorders. One prevalent mechanism of endothelial dysfunction is an increase in reactive oxygen species under oxidative stress. Previous reports have demonstrated that hydrogen peroxide (H ₂O ₂), a highly stable reactive oxygen species that modulates physiological signaling pathways, also enhances endothelial permeability, but the mechanism of this effect is unknown. Here, we identify the actin-binding protein myristoylated alanine-rich C-kinase substrate (MARCKS) as a key mediator of the H ₂O ₂-induced permeability change in bovine aortic endothelial cells. MARCKS knockdown and H ₂O ₂ treatment alter the architecture of the actin cytoskeleton in endothelial cells, and H ₂O ₂ induces the phosphorylation and translocation of MARCKS from the cell membrane to the cytosol. Using pharmacological inhibitors and small interference RNA constructs directed against specific proteins, we uncover a signaling cascade from Rac1 to Abl1, phospholipase Cγ1, and PKCδ that is triggered by H ₂O ₂ and leads to MARCKS phosphorylation. Our findings establish a distinct role for MARCKS in the regulation of H ₂O ₂-induced permeability change in endothelial cells, and suggest potential new therapeutic targets for the treatment of disorders involving oxidative stress and altered endothelial permeability. |
---|---|
Bibliography: | http://dx.doi.org/10.1073/pnas.1204974109 Author contributions: B.Y.J., A.J.L., and T.M. designed research; B.Y.J. and A.J.L. performed research; B.Y.J., A.J.L., D.E.G., and T.M. analyzed data; and B.Y.J., A.J.L., D.E.G., and T.M. wrote the paper. Edited by Michael A. Marletta, University of California, Berkeley, CA, and approved August 7, 2012 (received for review March 26, 2012) |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1204974109 |